21025 ⎘
Medicinal preparations containing peptides; Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof; Enzymes; Proenzymes; Derivatives thereof Transferases (2)
Homogenous antibody drug conjugates via enzymatic methods
#602Homogenous antibody drug conjugates via enzymatic methods
#603Vaccines against an oncogenic isoform of HER2 (ErbB2) and methods of using the same
#604Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#605Pharmaceutical kit comprising erythrocytes encapsulating a PLP-dependent enzyme and, a non-phosphate PLP precursor
#606Treatment and prevention of ocular neurodegenerative disorder
#607NAD BIOSYNTHESIS AND PRECURSORS FOR THE TREATMENT AND PREVENTION OF CANCER AND PROLIFERATION
#608SELECTIVE INSERTION OF SUICIDE GENES INTO CANCER CELLS
#609Transduction buffer
#610Vaccines against an oncogenic isoform of ESR1 and methods of using the same
#611Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#612Modified Polynucleotides for the production of biologics and proteins associated with human disease
#613COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#614TREATMENT OF OCULAR NEOVASCULARIZATION USING ANTI-VEGF PROTEINS
#615Compositions and methods for the treatment of cancer
#616Compositions and methods for enhancing CRISPR activity by POLQ inhibition
#617Compositions and methods for regulating activity of inhibitor of DNA binding-2 (ID2) protein and for treating ID protein-related diseases
#618Compositions for treating heart disease by inhibiting the action of mAKAP-β
#619Immunogenic compositions and reagents for preparing
#620PROCESS FOR CONCENTRATION OF A POLYPEPTIDE
#621COMPOSITIONS AND METHODS FOR DIAGNOSIS AND TREATMENT OF PERVASIVE DEVELOPMENTAL DISORDER
#622METHODS AND PRODUCTS FOR NUCLEIC ACID PRODUCTION AND DELIVERY
#623Method and composition for treatment of hair loss
#624Use of creatine kinase and derived peptides thereof to relieve pain
#625ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases
#626NME Inhibitors and Methods of Using NME Inhibitors
#627Compositions and methods for modulating FMR1 expression
#628Universal cancer vaccine
#629CLATHRIN THERAPEUTIC FOR NEUROPSYCHIATRIC DISEASES & DISORDERS
#630CLATHRIN THERAPEUTIC FOR PSYCHIATRIC DISORDERS
#631Methods and materials for GALGT2 gene therapy
#632Molecular signature of cancer
#633METHODS OF TREATING PARKINSON'S DISEASE USING VIRAL VECTORS
#634COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#635Delivery of negatively charged proteins using cationic lipids
#636MRNA for use in treatment of human genetic diseases
#637Composition for anticancer adjuvant comprising RIP3 expression promoter as active ingredient, method for screening anticancer adjuvant which promotes RIP3 expression and enhances sensitivity of anticancer agent, and method for monitoring sensitivity of anticancer agent
#638MEl'hods and means for diagnosing spondylarthritis using autoantibody markers
#639Compositions and methods for treating pulmonary hypertension
#640Treatments of oxidative stress conditions
#641NAP-2 polypeptides and methods for modulating immune system activity in heart tissue
#642PEPTIDE HAVING FIBROSIS INHIBITORY ACTIVITY AND COMPOSITION CONTAINING SAME
#643PROTEIN COATING COMPOSITION
#644Methods for treating ulcers in a hemoglobinopathy anemia with a soluble actRIIB polypeptide
#645Peptides and compositions for treatment of joint damage
#646Reduction of lipase activity in product formulations
#647Method for treatment or prevention of a cancer
#648Compounds and methods for the targeted degradation of enhancer of zeste homolog 2 polypeptide
#649COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#650COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#651Cleavable lipids
#652COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#653COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#654COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#655COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#656Process of Preparing mRNA-Loaded Lipid Nanoparticles
#657METHOD OF TREATING NEUROLOGICAL DISORDER BY ENHANCING OUTGROWTH OF NEURITE
#658MODULATION OF AXL RECEPTOR ACTIVITY IN COMBINATION WITH CYTOREDUCTIVE THERAPY
#659Transposon, gene transfer system and method of using the same
#660CMLCK GENE TRANSFER
#661METHODS FOR CONTROLLING OBESITY USING MINIMALLY INVASIVE MEANS
#662Engineered toxin adapted to deliver molecules into selected cells
#663COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#664Treatment of ocular neovascularization using anti-VEGF proteins
#665Targeting NAD to treat chemotherapy and radiotherapy induced cognitive impairment, neuropathies and inactivity
#666COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#667Methods for inducing cell division of postmitotic cells
#668MUTANT HUMAN DEOXYCYTIDINE KINASE
#669PINK1 C-terminal domain polypeptide and methods using the same in cancer treatment
#670AGENTS, SYSTEMS AND METHODS FOR TREATING CANCER
#671Dosing strategies for targeting EPCAM positive bladder cancer
#672THERAPEUTIC COMPOSITIONS AND METHODS OF USE FOR TREATING CANCER
#673METHODS AND COMPOSITIONS FOR THE TREATMENT OF EPIDERMOLYSIS BULLOSA
#674Delivery of structurally diverse polypeptide cargo into mammalian cells by a bacterial toxin
#675Antibacterial composition for combating carbapenem-resistant gram-negative bacteria comprising ADK protein as active ingredient
#676GLUTAMATE OXALOACETATE TRANSAMINASE 1 (GOT1), PREPARATIONS AND METHODS OF GENERATING SAME AND USES THEREOF
#677Antifibrotic activity of GAS6 inhibitor
#678Tumor specific oligosaccharide epitopes and use thereof
#679Compositions and methods for treating pulmonary hypertension
#680TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#681Peptide for preventing hearing loss, and composition comprising same
#682METHODS AND COMPOSITIONS FOR TREATMENT OF FORBES-CORI DISEASE
#683Use of pertussis toxin as a therapeutic agent
#684Methods and products for nucleic acid production and delivery
#685Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
#686Messenger RNA therapy for the treatment of ornithine transcarbamylase deficiency
#687Compositions and methods of increasing longevity or treating cellular stress
#688Cleavable Lipids
#689Single-vector gene construct comprising insulin and glucokinase genes
#690MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF
#691Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#692Compositions and methods for CaMKII inhibitors and uses thereof
#693Methods and compositions for reducing blood glucose levels
#694Methods for treating and preventing cardiomyopathy with a fusion protein of tafazzin and a cellular permeability peptide
#695EXTRACELLULAR VESICLES WITH ENHANCED POTENCY
#696FIBROTIC TISSUE STABILIZED BY CROSSLINKING FOR TREATMENT OF SNORING AND OBSTRUCTIVE SLEEP APNEA
#697Ligand binding molecules and uses thereof
#698In vivo production of proteins
#699Combination Therapy For Cancer
#700CAMKK1 as a novel regenerative therapeutic
#701Anti-Inflammatory Peptides and Composition Comprising the Same
#702Peptides and compositions for treatment of joint damage
#703Efficient delivery of therapeutic molecules in vitro and in vivo
#704Multimeric coding nucleic acid and uses thereof
#705Neukinase, a downstream protein of neuregulin
#706Methods and compositions for in vivo induction of pancreatic beta cell formation
#707Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#708Method for controlling obesity using minimally invasive means
#709Compositions and methods relating to argininosuccinate synthetase
#710Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#711ARGININE METHYLTRANSFERASE INHIBITORS AND USES THEREOF
#712Anti-Inflammatory Peptides and Composition Comprising the Same
#713COMPOSITIONS AND METHODS COMPRISING THE USE OF A BACILLUS AGARADHAERENS INULOSUCRASE (INUO)
#714T-cell redirecting bispecific antibodies for treatment of disease
#715Universal cancer vaccine
#716POROUS NANOPARTICLE-SUPPORTED LIPID BILAYERS (PROTOCELLS) FOR TARGETED DELIVERY INCLUDING TRANSDERMAL DELIVERY OF CARGO AND METHODS THEREOF
#717Telomerase reverse transcriptase-based therapies
#718PiggyBac transposon variants and methods of use
#719CONDITIONAL CYTOTOXIC GENE THERAPY VECTOR FOR SELECTABLE STEM CELL MODIFICATION FOR ANTI HIV GENE THERAPY
#720Functionalized DNA Dendrimers For Gene Delivery To Cells
#721Method for controlling obesity using minimally invasive means
#722Method for controlling obesity using minimally invasive means
#723PROCESS FOR CONCENTRATION OF A POLYPEPTIDE
#724METHODS AND COMPOSITIONS FOR ENHANCING CANCER THERAPY
#725Recombinant AAV Vectors Expressing Osteoprotective genes, including HAS2 and Lubricin, useful in the Treatment of Osteoarthritis and Related Joint Conditions in Mammals
#726VACCINES AGAINST AN ONCOGENIC ISOFORM OF HER2 (ErbB2) AND METHODS OF USING THE SAME
#727VACCINES AGAINST AN ONCOGENIC ISOFORM OF ESR1 AND METHODS OF USING THE SAME
#728Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof
#729Telomerase reverse transcriptase-based therapies for treatment of conditions associated with myocardial infarction
#730Ocular Compositions and Methods Thereof
#731USE OF PHOSPHORYLATION PATHWAY-RELATED FACTOR IN REGULATING FUNCTION OF REGULATORY T CELL
#732LYMPHOCYTE MEDIATED DELIVERY OF PROTEINS
#733Methods and systems for predicting response to immunotherapies for treatment of cancer
#734Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#735Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#736Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#737Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#738USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER
#739METHODS AND PRODUCTS RELATING TO GSK3ß REGULATION
#740Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo
#741Human monoclonal antibodies specific for CD22
#742Anti-inflammatory peptides and composition comprising the same
#743Vault complexes for cytokine delivery
#744Mps1 and KNL1 phosphorylation system
#745COMPOSITIONS AND METHODS FOR TREATING CANCER
#746Methods for Generating Stably Linked Complexes Composed of Homodimers, Homotetramers or Dimers of Dimers and Uses
#747Aldehyde tags, uses thereof in site-specific protein modification
#748Methods and compositions for modulating immune tolerance
#749Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules
#750Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#751Anti-inflammatory peptides and composition comprising the same
#752Targeting of chondroitin sulfate glycans
#753Compositions targeting the interaction domain between p27KiP1 and Brk and methods of use thereof to inhibit p27 Y phosphorylation and cdk4 activity
#754Covalently linked polypeptide toxin-antibody conjugates
#755Lipid vesicle compositions and methods of use
#756Enhancing health in mammals using telomerase reverse transcriptase gene therapy
#757COMPOSITION TO REPURPOSE DRUGS
#758Treatment of hyperbilirubinemia
#759Peptide having fibrosis inhibitory activity and composition containing same
#760Mutant huntingtin-mediated protein dysfunction
#761T-cell redirecting bispecific antibodies for treatment of disease
#762Cancer Therapy
#763STEM CELLS FOR ANTI-ANGIOGENIC THERAPY IN AGE-RELATED MACULAR DEGENERATION, DIABETIC RETINOPATHY, CORNEAL VASCULARISATION AND CANCER
#764Targeting of chondroitin sulfate glycans
#765Chimeric antigen receptor (CAR) signalling system
#766Methods and materials for reducing the severity of viral infections
#767Polymer particles and uses thereof
#768COMPOSITION FOR ACCELERATING PENETRATION THROUGH SKIN, PREPARATION FOR TRANSDERMAL ADMINISTRATION, AND SKIN PATCH PREPARATION
#769Compositions and methods to promote wound healing
#770MOLECULE ASSOCIATED WITH ONSET OF GOUT, AND METHOD AND KIT FOR EVALUATING DIATHESIS OF URIC ACID-RELATED DISEASES AND INFLAMMATION-RELATED DISEASES, AND INSPECTION OBJECT AND DRUG
#771COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#772Target for diabetes treatment and prevention
#773METHODS FOR ANALYSIS OF SOMATIC MOBILE ELEMENTS, AND USES THEREOF
#774Peptide capable of silica deposition and use thereof
#775Peptides and compositions for treatment of joint damage
#776Compositions for in vivo expression of therapeutic sequences in the microbiome
#777Vault immunotherapy
#778Method of treatment using a pharmaceutical composition comprising erythrocytes encapsulating a PLP-dependent enzyme and its cofactor
#779Nutritive polypeptides and formulations thereof, and methods of production and use thereof
#780NME Inhibitors and Methods of Using NME Inhibitors
#781Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods
#782COMPOSITIONS AND METHODS FOR PROVIDING ACTIVE TELOMERASE TO CELLS IN VIVO
#783COMPOSITIONS AND METHOD FOR MANIPULATING PIM-1 ACTIVITY IN CIRCULATORY SYSTEM CELLS
#784Methods and products for nucleic acid production and delivery
#785COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
#786Adeno-associated viral (AAV) vectors useful for transducing adipose tissue
#787Method of reducing accumulation of intracellular tingible body macrophages
#788Compositions and formulations for treatment of gastrointestinal tract malabsorption diseases and inflammatory conditions and methods of production and use thereof
#789Reduction of lipase activity in product formulations
#790Coupling endonucleases with end-processing enzymes drives high efficiency gene disruption
#791TGF-beta superfamily type I and type II receptor heteromultimers and uses thereof
#792ALK7:ActRIIB heteromultimers and uses thereof
#793Peptide having angiogenesis inhibitory activity and composition containing same
#794ULK1 COMPOSITIONS, INHIBITORS, SCREENING AND METHODS OF USE
#795Compositions and methods for suppression of inhibitor formation against coagulation factors in hemophilia patients
#796BACTERIAL ANTI-PHAGE DEFENSE SYSTEMS
#797THERAPEUTIC COMPOSITIONS INCLUDING MODULATORS OF deltaPKC AND/OR epsilonPKC, AND USES THEREOF
#798TARGETING GDF6 AND BMP SIGNALING FOR ANTI-MELANOMA THERAPY
#799Transduction buffer
#800TREATING CANCER STEM CELLS USING TARGETED CARGO PROTEINS
#801Nucleic acids encoding SB10 variants
#802COMPOSITION FOR PREVENTING OR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING ADK PROTEIN AS ACTIVE INGREDIENT
#803NEW METHODS TO PRODUCE ACTIVE TERT
#804Composition for treating and preventing benign prostatic hyperplasia
#805Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof
#806Peptides and compositions for treatment of joint damage
#807TRANSGLUTAMINASE 4 AS A PROSTATE SPECIFIC AUTOANTIGEN AND THE METHODS OF USE THEREOF
#808CCR3 MODULATION IN THE TREATMENT OF AGING-ASSOCIATED IMPAIRMENTS, AND COMPOSITIONS FOR PRACTICING THE SAME
#809Antiviral activity of Gas6 inhibitor
#810METHOD
#811Using nucleic acids encoding NAP-2 and TGF-alpha polypeptides to improve cardiac function
#812Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor
#813Delivery system for functional nucleases
#814METHODS OF PROMOTING FAT LOSS COMPRISING ADMINISTERING AN ALK7 INHIBITOR
#815MODULATION OF AXON DEGENERATION
#816Polypeptide targeting to mitochondria
#817Process for concentration of a polypeptide
#818Molecular signature of cancer
#819PROLAMIN-BASED FILM AND METHOD FOR MANUFACTURING PROLAMIN-BASED ORAL FILM FOR PROTECTING ACTIVITY OF ANTI-OXIDATIVE MATERIAL
#820COMPLEXES OF RNA AND CATIONIC PEPTIDES FOR TRANSFECTION AND FOR IMMUNOSTIMULATION
#821FLT4 (VEGFR-3) AS A TARGET FOR TUMOR IMAGING AND ANTI-TUMOR THERAPY
#822Compositions and methods for the treatment of cancer
#823T-cell redirecting bispecific antibodies for treatment of disease
#824T-Cell Redirecting Bispecific Antibodies for Treatment of Disease
#825Fusion proteins and methods for treating HIV infection and AIDS related symptoms
#826Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
#827Modified polynucleotides for the production of proteins
#828Methods, compositions, and kits for improving pancreatic beta cell viability and treating diseases or conditions related to beta cell destruction
#829Compositions, methods, and devices for dialysis
#830Method of modulating sex hormone levels using a sex hormone secretion modulator
#831Structure, manufacturing and uses of human-derived cell-permeable peptides conjugated with specific biologically active cargo peptides
#832Chimeras of lumazine synthase and beta subunit of ABtoxins
#833TUMOR THERAPY WITH REPLICATION COMPETENT SINDBIS VIRAL VECTORS
#834Methods and compositions for delivering active agents with enhanced pharmacological properties
#835Composition for preventing or treating autoimmune disease, comprising, as active ingredient, PINK1 protein or polynucleotide encoding same
#836Compositions and methods for treatment of retinal degenerative diseases
#837MODULATORS OF ADP-DEPENDENT GLUCOKINASE (ADPGK) AND GLYCEROL-3-PHOSPHATE DEHYDROGENASE (GPD2) FOR THERAPY
#838ACTRIIB-FC POLYNUCLEOTIDES, POLYPEPTIDES, AND COMPOSITIONS
#839Inhibition of AXL Signaling in Anti-Metastatic Therapy
#840ABHD5 and partial HDAC4 fragments and variants as a therapeutic approach for the treatment of cardiovascular diseases
#841FUNCTIONAL GHRELIN RECEPTOR ANTAGONISM DURING PREGNANCY TO PREVENT STRESS-ASSOCIATED MENTAL ILLNESS IN OFFSPRING AND MOTHERS
#842SINGLE-DOSE ADMINISTRATION OF FACTOR VIIa
#843mRNA for use in treatment of human genetic diseases
#844Method for reducing blood glucose
#845METHODS AND COMPOSITIONS FOR TREATMENT OF FORBES-CORI DISEASE
#846Methods of using VEGF-C biomarkers for age-related macular degeneration (AMD) diagnosis
#847Composition and methods for treating ischemic damage
#848Modified polynucleotides for the production of biologics and proteins associated with human disease
#849Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases
#850Selective Sensitization of Cancer Cells to, and Selective Protection of Non-Cancer Cells from Genotoxic Therapies
#851Treatment of Operable High-Grade Glioma With Sitimagene Ceradenovec Gene Therapy and Ganciclovir
#852Botulinum Chimera Compositions for Axonal Regenerative Therapy During Spinal Cord Injury
#853Process for the preparation of erythrocytes loaded with one or more substances of pharmaceutical interest and so obtained erythrocytes
#854Methods for treating ulcers in thalassemia syndrome with an ActRIIB polypeptide
#855Method and compositions for treatment of calcineurin-related diseases
#856Treatment of myocardial infarction by inhibiting the action of mAKAPβ
#857Combination of immunotherapies with activators of Tie-2
#858Lipid vesicle compositions and methods of use
#859Method of deriving mature hepatocytes from human embryonic stem cells
#860HIV-1 integrase derived peptides and compositions
#861Glycosylated VEGF decoy receptor fusion protein
#862Bivalent IL-2 fusion toxins
#863Method of treating eye disease using glycosylated VEGF decoy receptor fusion protein
#864CHEMOTHERAPY-RESISTANT IMMUNE CELLS
#865PURINE NUCLEOSIDE PHOSPHORYLASE AS ENZYMATIC ACTIVATOR OF NUCLEOSIDE PRODRUGS
#866FAM150A, FAM150B, AND FAM150 ANTAGONISTS AND USES THEREOF
#867TAM RECEPTORS AS VIRUS ENTRY COFACTORS
#868ASSAY METHOD
#869METHODS TO PREDICT AND PREVENT RESISTANCE TO TAXOID COMPOUNDS
#870Antibodies to argininosuccinate synthase and related methods
#871Use of CD83 in Combination Therapies
#872Composition for preventing or treating sepsis
#873Compositions and methods for CaMKII inhibitors and uses thereof
#874PSEUDOMONAS EXOTOXINS FOR CANCER TREATMENT
#875Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate
#876VEGFR-3 ligand binding molecules and uses thereof
#877DNA TEMPLATES FOR SMALL RNA PRODUCTION IN MAMMALIAN CELLS
#878In vivo production of proteins
#879Proteins with modified glycosylation and methods of production thereof
#880Inhibitors of Branched-Chain-Aminotransferase-1 (BCAT1) for the Treatment of Brain Tumors
#881Protein to promote blood vessel growth and uses thereof
#882Topically administered, skin-penetrating glycosaminoglycan formulations suitable for use in cosmetic and pharmaceutical applications
#883Aerosolized fibrin hemostat
#884Composition for preventing or treating cachexia
#885Drug delivery means
#886Treatment of bone diseases
#887Methods of modulating immune responses by modifying Akt3 bioactivity
#888Recombinant adenovirus with increased safety and anticancer activities, and use thereof
#889Preservation and reconstitution of cell-free protein expression systems
#890METHOD FOR INDUCING CELLS TO LESS MATURE STATE
#891NAD biosynthesis and precursors for the treatment and prevention of cancer and proliferation
#892Compositions and methods for inducing liver regeneration by administering hepatocyte-derived exosomes
#893USE OF ACTIVIN RECEPTOR-LIKE KINASE 1 (ALK-1) ANTAGONISTS IN THE TREATMENT OF CANCER
#894ENHANCED NUCLEIC ACID CONSTRUCTS FOR EUKARYOTIC GENE EXPRESSION
#895Modification of enzymatic crosslinkers for controlling properties of crosslinked matrices
#896Methods of treating hemoglobinopathies
#897NAD BIOSYNTHESIS AND PRECURSORS IN THE PREVENTION AND TREATMENT OF INFLAMMATION
#898Preeclamptic placental mesenchymal stem cell conditioned medium for use in the treatment of a tumour
#899Methods for treating cardiac conditions
#900ST6GAL-1 MEDIATED MODULATION OF HEMATOPOIESIS